A Closer Look at FDA Decision to Pull Lorcaserin

(MedPage Today) -- FDA's decision to request the voluntary recall of the oral weight-loss drug lorcaserin (Belviq, Belviq XR) earlier this year came after a careful analysis of postmarketing safety data that revealed excess cancer risk and death...